GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » Issuance of Stock

Kancera AB (OSTO:KAN) Issuance of Stock : kr59.20 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Kancera AB Issuance of Stock?

Kancera AB's Issuance of Stock for the three months ended in Dec. 2024 was kr0.00 Mil.

Kancera AB's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was kr59.20 Mil.

Kancera AB Issuance of Stock Historical Data

The historical data trend for Kancera AB's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kancera AB Issuance of Stock Chart

Kancera AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 93.84 95.94 36.76 6.22 59.20

Kancera AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 59.20 -0.11 0.11 -

Kancera AB Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr59.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kancera AB Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Kancera AB's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Kancera AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kancera AB (OSTO:KAN) » Definitions » Issuance of Stock
Comparable Companies
OSTO:ACOU OSTO:ACTI OSTO:SPRINT OSTO:PILA XSAT:ABERA XSAT:BIOWKS OSTO:BIOSGN OSTO:IVACC OSTO:ALZCUR OSTO:ELIC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
3EE0:Germany
Address
Karolinska Institutet Science Park, Banvaktsvagen 22, Solna, SWE, 171 48
Website
http://www.kancera.com
Kancera AB develops drugs that counteract damage in acute and chronic inflammation. The fractalkin blockers KAND567 and KAND145 are developed to effectively counteract hyperinflamation in various disease states and thereby protect vital organs in conjunction with myocardial infarction and severe viral infections. Kancera is planning two phase II clinical trials, in covid-19 and in cardiac patients. The company conducts research and development within the Karolinska Institute Science Park in Stockholm.

Kancera AB Headlines

No Headlines